1-50418744-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032110.3(DMRTA2):āc.1550C>Gā(p.Ala517Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,558,864 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A517V) has been classified as Uncertain significance.
Frequency
Consequence
NM_032110.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152192Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000672 AC: 11AN: 163730Hom.: 0 AF XY: 0.0000653 AC XY: 6AN XY: 91824
GnomAD4 exome AF: 0.0000206 AC: 29AN: 1406672Hom.: 0 Cov.: 29 AF XY: 0.0000229 AC XY: 16AN XY: 697446
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152192Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2024 | The c.1550C>G (p.A517G) alteration is located in exon 3 (coding exon 2) of the DMRTA2 gene. This alteration results from a C to G substitution at nucleotide position 1550, causing the alanine (A) at amino acid position 517 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at